Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Innovative therapy ‘tricks’ and destroys cancer cells

April 11, 2022 Sales and Marketing

A novel therapy studied at the Medical College of Wisconsin (MCW) Cancer Centre is headed for clinical trial in patients …
News

World leaders pledge $4.8 billion in 2022 Break COVID Now Summit

April 11, 2022 Sales and Marketing

World leaders in Germany, Ghana, Indonesia, and Senegal came together in the 2022 Break COVID Now Summit, co-hosted by vaccine …
News

‘Killer’ immunotherapy shows early promise

April 11, 2022 Sales and Marketing

A first of its kind immunotherapy which uses the immune system’s ‘natural killer cells’ could offer potential against a range …
News
leipzig_skyline

FlyPharma Conference Europe: New dates and location announced

April 4, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022.
News

AI test could predict effective cancer drug combinations in less than two days

April 4, 2022 Sales and Marketing

Scientists have created a prototype test that can predict which drug combinations are likely to work for cancer patients in …
News

FDA accepts Dupixent for Priority Review in patients 12+ with eosinophilic esophagitis

April 4, 2022 Sales and Marketing

The FDA has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab), in patients aged 12 …
News

New centre targets ‘undruggable’ cancers

April 4, 2022 Sales and Marketing

The new Centre for Protein Degradation has been launched, made possible by a £9 million donation to The Institute of …
News

COVID-19 vaccines now available for five to 11-year olds in England

April 4, 2022 Sales and Marketing

Parents and carers of five to 11-year olds in England can now book a low-dose COVID-19 vaccine for their children. …
News

NICE does not recommend icosapent ethyl for prevention of cardiovascular events

March 28, 2022 Sales and Marketing

NICE has published further draft guidance for public consultation which does not recommend VAZKEPA (icosapent ethyl) for reducing the risk …
News

FDA approve oral solution for rare childhood epilepsy

March 28, 2022 Sales and Marketing

UCB has announced that FINTEPLA® (fenfluramine) oral solution CIV has been approved by the FDA for the treatment of seizures …
News

EMA review first novel gene therapy candidate for haemophilia B

March 28, 2022 Sales and Marketing

CSL Behring has today announced that the EMA has accepted the Marketing Authorising Application for etranacogene dezaparvovec (EtranaDez), under its …
News

Pregnant women to receive life-saving pre-eclampsia check on NHS

March 28, 2022 Sales and Marketing

A life-saving blood test that can help diagnose suspected preterm pre-eclampsia has been recommended by NICE, and this is to …
News
guy_photo_2022_002

Ipsen appoints Guy Oliver as General Manager, UK & Ireland

March 21, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ipsen have announced the appointment of Guy Oliver as General Manager of its UK and Ireland affiliate. Guy brings a …
Appointment

FDA approval for first in class immunotherapy for advanced melanoma

March 21, 2022 Sales and Marketing

The FDA has approved Bristol-Myers Squibb’s Opdualag (nivolumab and relatlimab-rmbw), the first drug in a new class of cancer immunotherapies, …
News

Spring COVID-19 booster launches for over-75s and high risk in England

March 21, 2022 Sales and Marketing

Those aged 75 and over, alongside residents in care homes and those with weakened immune systems, can now book an …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026